Longevity Labs+ is an Austrian biotech company focusing on cell ageing, autophagy and the prevention of age-related diseases. With the spermidineLIFE brand, the company makes scientific findings on spermidine accessible to consumers. The aim of the collaboration was to make Longevity Labs+’s scientific expertise visible in the media and to position spermidineLIFE® as a research-based premium product.
Client
TLL The Longevity Labs GmbH
Location
Graz, Austria
Industry
Pharmaceuticals & biotech
Target audience
B2C
Services
- Public relations (PR)
Geographic scope
International
Period
Jan 2021 – Dec 2023
Overview
Challenge
Health and food supplement topics are heavily regulated and at the same time sensitive in public perception. The challenge was to prepare complex study results on autophagy, cognition and neurodegenerative diseases accurately, clearly and in a media-friendly way, without any medical promises of cure. At the same time, trust was to be built among media, consumers and the specialist public.
Solution
To achieve these goals, a continuous PR strategy was implemented that combined scientific study communications, product PR, CSR topics and awards. Key measures included preparing and placing clinical studies in the media, among others in collaboration with Charité Berlin and the Geriatric Health Centres Graz, as well as communicating social initiatives such as product donations to nursing staff.
In addition, award PR was carried out around the German Innovation Award, to further underline the brand’s innovative strength and scientific quality.
Impact
Through continuous media relations, Longevity Labs+ was established as a credible player in longevity research. The placement of scientific content, CSR topics and awards helped position spermidineLIFE® as an evidence-based product with a clear research focus. The coverage lastingly strengthened brand awareness and trust in the company’s scientific competence.